Meropenem resistance and MIC-Based pharmacodynamic implications among clinical pseudomonas aeruginosa isolates from wound and burn infections
MedNEXT Journal of Medical and Health Sciences · 15.11.2026 · 7 (4)
DOI: 10.54448/mdnt26404 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedNEXT Journal of Medical and Health Sciences, online erschienen am 15.11.2026. Verfasst von Essmat Jamal Jamel. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Pseudomonas aeruginosa is one of the most difficult pathogens to treat in wound and burn infections and resistance to meropenem is a significant concern. This study aimed to examine meropenem MICs, meropenem resistance patterns and their implications for pharmacodynamic optimization and antimicrobial stewardship. Materials and Methods: This was a cross-sectional study in a laboratory setting. A total of 100 patients with wound or burn infections were included in the study at Azadi Teaching Hospital in Kirkuk, Iraq, from February to November 2024. Thirty non-duplicate P. aeruginosa isolates were recovered. The samples were grown on MacConkey and cetrimide agars. In Sulaymaniyah, Iraq, the identification and susceptibility testing of bacteria were performed using the BD Phoenix automated system with NMIC/ID-431 panels. Meropenem MICs and susceptibility classifications were directly obtained from the automated reports. Fisher's exact test was used to compare resistance between specimen sources (two-sided).
Results
Thirty (30.0%) patients were positive for P. aeruginosa. Among the 30 isolates, 13 (43.3%) were susceptible, four (13.3%) intermediate, and 13 (43.3%) resistant to meropenem. The MIC50 was 4 µg/mL, and the MIC90 was >4 µg/mL. The burn isolates (73.3%) were significantly more likely to be meropenem resistant than the wound isolates (13.3%) (p = .00251).
Conclusion
These results show high levels of meropenem resistance in clinical P. aeruginosa isolates, especially those from burn infections. The resulting MIC distribution underscores the importance of both susceptibility and pharmacodynamics in the clinical selection of an antimicrobial agent. The results highlight the importance of enhancing local resistance surveillance, personalized therapeutic decision-making and antimicrobial stewardship strategies for optimal wound and burn infection management.
Zitieren
APA
Jamel, E. J. (2026). Meropenem resistance and MIC-Based pharmacodynamic implications among clinical pseudomonas aeruginosa isolates from wound and burn infections. MedNEXT Journal of Medical and Health Sciences, 7(4). https://doi.org/10.54448/mdnt26404
Vancouver
Jamel EJ. Meropenem resistance and MIC-Based pharmacodynamic implications among clinical pseudomonas aeruginosa isolates from wound and burn infections. MedNEXT Journal of Medical and Health Sciences. 2026;7(4). doi:10.54448/mdnt26404
BibTeX
@article{Jamel2026,
author = {Jamel, Essmat Jamal},
title = {Meropenem resistance and MIC-Based pharmacodynamic implications among clinical pseudomonas aeruginosa isolates from wound and burn infections},
journal = {MedNEXT Journal of Medical and Health Sciences},
year = {2026},
volume = {7},
number = {4},
doi = {10.54448/mdnt26404}
}
EUVIMED